Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Abroad (travel likely)RecruitingPHASE2
Conditions
Breast Neoplasm · Breast Cancer · Breast Tumors · Triple-Negative Breast Cancer (TNBC) · HER2-positive Breast Cancer · HER2-negative Breast Cancer · Hormone Receptor Positive Tumor · Hormone Receptor Negative Tumor · Early-stage Breast Cancer · Locally Advanced Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University Shanghai Cancer Center Shanghai, China, 200032, Shanghai, Shanghai Municipality, China
Study leads
Zhimin Shao, Professor
Principal Investigator
Fudan University